1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Obsessive-Compulsive Disorder: new trials by email Literature Review of Obsessive-Compulsive Disorder trials Research Report on Obsessive-Compulsive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder Nabilone, Placebo - Obsessive-Compulsive Disorder | Phase 1 / Phase 2 | Withdrawn | New York State Psychiatric Institute | 2022-03-01 | 2024-05-21 |
Anxiety Disorders (1) · Mental Disorders (1)
nabilone (1)
New York State Psychiatric Institute (1)
United States (1)
K23MH125315 (1)